Dafydd Watts
PFD Report
Historic (No Identified Response)
Ref: 2014-0194
Coroner's Concerns (AI summary)
Drug literature and the British National Formulary fail to adequately inform physicians about rare but potential fatal occurrences associated with medication.
View full coroner's concerns
Although the evidence suggests that this is only the fourth such death documented it appears that the possibility (albeit remote) of such an occurrence is not drawn to physicians attention in the drug literature or in the BNF entry:
Sent To
Response Status
Linked responses
0 of 2
56-Day Deadline
28 Jun 2014
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Report Sections
Investigation and Inquest
On commenced an investigation into the death of Dafydd Rhys WATTS, Aged 34. The investigation concluded at the end of the inquest on 14th March 2014. The conclusion of the inquest was; la Pericarditis Ib Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) Ic Epilepsy treated with levetiracetam Conclusion; Dafyyd Watts died suddenly of pericarditis following an unrecognised and exceptionally rare drug reaction to his necessary anti-epileptic treatment
Circumstances of the Death
The deceased died of eosinophilic pericarditis and DRESS syndrome due to Levetiracetam He had previously been prescribed Carbamazepine but suffered pulmonary eosinophilia. He ceased this treatment and started Levetiracetam_
Action Should Be Taken
In my opinion action should be taken to prevent future deaths and believe your organisation have the power to take such action.
Similar PFD Reports
Reports sharing organisations, categories, or themes
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.